Gene therapy for Parkinson’s disease

By Le Hoang N   Frim David M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 151-161

Informa Healthcare

Access to resources Recommend Favorite

-Synuclein and the Pathogenesis of Parkinson's Disease

By  

Protein and Peptide Letters, Vol. 11, Iss. 3, 2004-06 ,pp. : 229-237

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomic approach to studying parkinson’s disease

By Zhang Jing   Goodlett David  

Molecular Neurobiology, Vol. 29, Iss. 3, 2004-06 ,pp. : 271-288

Humana Press, Inc

Access to resources Recommend Favorite

Environmental toxins and α-synuclein in Parkinson’s disease

By Liu Yanying   Yang Hui  

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 273-282

Humana Press, Inc

Access to resources Recommend Favorite

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease

By Bonsi P.   Cuomo D.   Picconi B.   Sciamanna G.   Tscherter A.   Tolu M.   Bernardi G.   Calabresi P.   Pisani A.  

Amino Acids, Vol. 32, Iss. 2, 2007-02 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite